文献速递烧伤创面修复

二磷酸腺苷核糖基化因子6抑制通过维持血管完整性和抑制ASC炎症小体传播保护烧伤脓毒症诱导的肺损伤

Adenosine diphosphate ribosylation factor 6 inhibition protects burn sepsis induced lung injury through preserving vascular integrity and suppressing ASC inflammasome transmission.
PubMed 文献 · Burns · 2024-01-15

该研究在雄性C57BL/6小鼠中建立烧伤脓毒症模型,烧伤后立即腹腔注射ARF6小分子抑制剂NAV-2729或溶媒,观察肺组织损伤、血管通透性、VE-钙黏蛋白表达及炎症指标。结果显示NAV-2729减轻烧伤脓毒症诱导的肺损伤并提高生存率,机制涉及抑制ARF6激活、恢复VE-钙黏蛋白表达及抑制ASC斑点的吞噬和细胞间传播。作者认为ARF6抑制可能保护烧伤脓毒症时的肺功能并改善结局。

要点

  • NAV-2729减轻烧伤脓毒症小鼠肺损伤并提高生存率。
  • NAV-2729通过抑制ARF6激活恢复VE-钙黏蛋白表达维持血管完整性。
  • NAV-2729抑制ARF6依赖的ASC斑点吞噬,阻断炎症细胞间传播。

核心结论

  • ARF6抑制通过恢复VE-钙黏蛋白表达维持血管完整性,并通过影响ASC斑点吞噬抑制炎症扩散,从而保护烧伤脓毒症动物的肺损伤并改善生存。
  • 作者认为ARF6抑制可能作为保护烧伤脓毒症肺功能、改善结局的潜在治疗策略。

研究设计与样本

  • 在雄性C57BL/6小鼠中建立烧伤脓毒症模型:30% TBSA全层烧伤后痂下注射脂多糖。
  • 动物在烧伤和脓毒症刺激后立即腹腔注射ARF6小分子抑制剂NAV-2729或溶媒。
  • 大鼠肺微血管内皮细胞(PMVECs)用烧伤脓毒症血清刺激,加或不加10 μM NAV-2729。
  • 两组比较采用Student t检验,多组比较采用方差分析及Tukey事后检验。

主要发现

  • NAV-2729治疗减轻烧伤脓毒症诱导的肺损伤,并通过保持内皮细胞黏附连接中VE-钙黏蛋白表达、限制肺组织血管高通透性促进烧伤脓毒症小鼠生存。
  • NAV-2729减轻肺组织炎症因子表达和炎症损伤。
  • NAV-2729通过抑制ARF6激活、恢复PMVECs中VE-钙黏蛋白表达增强血管完整性。
  • NAV-2729抑制ARF6依赖的ASC斑点吞噬,阻止ASC斑点细胞间传播介导的炎症扩散。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe burns are devastating injuries with significant immune dysfunction and result in substantial mortality and morbidity due to sepsis induced organ failure. Acute lung injury is the most common type of organ injury in sepsis, however, the mechanisms of which are poorly understood and effective therapeutic measures are limited. This study is aimed to investigate the effect of a small Guanosine triphosphatase (GTPase), Adenosine diphosphate ribosylation factor 6 (ARF6), on burn sepsis induced lung injury, and discuss the possible mechanisms. METHODS: Burn sepsis was established in male C57BL/6 mice. Mice were anesthetised by intramuscular injection of ketamine and xylazine hydrochloride, then 30% TBSA full thickness burn followed by sub-eschar injection of lipopolysaccharide. Animals were treated with intraperitoneal injection of a small molecule inhibitor of ARF6: NAV-2729, or vehicle, right after the burn and sepsis stimuli were inflicted. Lung tissues were harvested for histopathological observation and the acute lung injury scores were calculated. Organ permeability, Vascular Endothelial Cadherin (VE-cadherin) expression, inflammatory cytokine levels and myeloperoxidase activity in lung tissues were detected. Rat pulmonary microvascular endothelial cells (PMVECs) were stimulated by burn sepsis serum with or without 10 μM NAV-2729. The ARF6 activation, VE-cadherin expression, inflammasome activity, adapter protein apoptosis speck-like protein containing a caspase recruiting domain (ASC) specks and cytokines secretion were determined. Student's t test was used for comparison between two groups. Multiple comparisons among groups were performed by using analysis of variance, with Tukey's test for the post hoc test. RESULTS: NAV-2729 treatment attenuated burn sepsis induced lung injury and promoted survival of burn septic mice by preserving VE-cadherin expression in endothelial cell adherent junction and limited vascular hyperpermeability in lung tissues. Moreover, inflammatory cytokine expression and inflammatory injury in lung tissues were alleviated. Mechanistically, NAV-2729 enhanced vascular integrity by inhibiting ARF6 activation and restoring VE-cadherin expression in PMVECs. In addition, NAV-2729 inhibited ARF6-dependent phagocytosis of ASC specks, thus preventing inflammation propagation mediated by cell-to-cell transmission of ASC specks. CONCLUSIONS: ARF6 inhibition preserved vascular integrity by restoring expression of VE-cadherin and suppressed the spread of inflammation by affecting phagocytosis of ASC specks, thus protected against sepsis induced lung injury and improve survival of burn septic animals. The findings of this study implied potential therapeutics by which ARF6 inhibition can protect lung function from septic induced lung injury and improve outcomes in burn sepsis.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Xiao M, Zhang P, Chen Z, et al. Adenosine diphosphate ribosylation factor 6 inhibition protects burn sepsis induced lung injury through preserving vascular integrity and suppressing ASC inflammasome transmission. Burns. 2024. PMID: 38267288. doi:10.1016/j.burns.2024.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。